No glycemic benefit from guar administration in NIDDM.
A randomized crossover study of 5-g guar minitablets against placebo, given three times per day with main meals for 8 wk, was done in 29 non-insulin-dependent diabetes mellitus (NIDDM) patients who had near-normal fasting plasma glucose concentrations on treatment with diet alone, additional sulfony...
Główni autorzy: | Holman, R, Steemson, J, Darling, P, Turner, R |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
1987
|
Podobne zapisy
-
LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS
od: Holman, R, i wsp.
Wydane: (1984) -
Insulin use in NIDDM. Rationale based on pathophysiology of disease.
od: Turner, R, i wsp.
Wydane: (1990) -
Treatment of NIDDM - Progressive requirement for polypharmacy to attain glycaemic goals
od: Cull, C, i wsp.
Wydane: (1997) -
Effects of ethnicity on metabolic control during the first six years of NIDDM
od: Davis, T, i wsp.
Wydane: (1997) -
Coronary heart disease and risk factors in NIDDM--experience from the United Kingdom Prospective Diabetes Study.
od: Turner, R, i wsp.
Wydane: (1997)